Viewing Study NCT03170232


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-25 @ 7:17 PM
Study NCT ID: NCT03170232
Status: TERMINATED
Last Update Posted: 2020-07-31
First Post: 2017-05-18
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-10-16
Start Date Type: ACTUAL
Primary Completion Date: 2018-11-15
Primary Completion Date Type: ACTUAL
Completion Date: 2018-11-15
Completion Date Type: ACTUAL
First Submit Date: 2017-05-18
First Submit QC Date: None
Study First Post Date: 2017-05-30
Study First Post Date Type: ACTUAL
Results First Submit Date: 2019-11-12
Results First Submit QC Date: None
Results First Post Date: 2020-02-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-07-14
Last Update Post Date: 2020-07-31
Last Update Post Date Type: ACTUAL